Hi Guest
X
Real-Time Quote
Enter Company or MFGlenmark Pharmaceuticals Ltd. - Research Center
Results | |
Statement | |
More |
Ratio |
Ratios
| Mar ' 09 | Mar ' 08 | Mar ' 07 | Mar ' 06 | Mar ' 05 | |
|---|---|---|---|---|---|
Per share ratios | |||||
| Adjusted EPS (Rs) | 5.27 | 15.91 | 11.48 | 5.49 | 5.29 |
| Adjusted cash EPS (Rs) | 6.03 | 17.09 | 13.43 | 6.96 | 6.55 |
| Reported EPS (Rs) | 8.70 | 15.64 | 11.17 | 5.55 | 5.29 |
| Reported cash EPS (Rs) | 9.46 | 16.82 | 13.12 | 7.02 | 6.56 |
| Dividend per share | 0.40 | 0.70 | 0.80 | 0.70 | 0.70 |
| Operating profit per share (Rs) | 9.25 | 20.22 | 17.94 | 8.92 | 9.68 |
| Book value (excl rev res) per share (Rs) | 8.46 | 41.34 | 37.49 | 25.16 | 22.48 |
| Book value (incl rev res) per share (Rs.) | 8.46 | 41.34 | 37.49 | 25.16 | 22.48 |
| Net operating income per share (Rs) | 34.53 | 55.48 | 67.45 | 47.62 | 41.77 |
| Free reserves per share (Rs) | 47.29 | 39.53 | 33.82 | 23.16 | 20.47 |
Profitability ratios | |||||
| Operating margin (%) | 26.77 | 36.44 | 26.59 | 18.72 | 23.18 |
| Gross profit margin (%) | 24.56 | 34.31 | 23.70 | 15.63 | 20.16 |
| Net profit margin (%) | 24.03 | 28.03 | 16.24 | 11.62 | 12.71 |
| Adjusted cash margin (%) | 16.66 | 30.63 | 19.52 | 14.51 | 15.71 |
| Adjusted return on net worth (%) | 10.73 | 38.48 | 30.61 | 21.81 | 23.52 |
| Reported return on net worth (%) | 17.71 | 37.83 | 29.79 | 22.05 | 23.53 |
| Return on long term funds (%) | 17.34 | 37.95 | 23.43 | 12.17 | 14.92 |
Leverage ratios | |||||
| Long term debt / Equity | 0.19 | 0.23 | 1.01 | 1.80 | 1.60 |
| Total debt/equity | 0.86 | 0.51 | 2.02 | 2.50 | 1.71 |
| Owners fund as % of total source | 53.67 | 66.21 | 33.15 | 28.54 | 36.86 |
| Fixed assets turnover ratio | 3.91 | 3.42 | 2.52 | 2.01 | 2.24 |
Liquidity ratios | |||||
| Current ratio | 7.49 | 2.99 | 3.94 | 5.30 | 5.04 |
| Current ratio (inc. st loans) | 1.82 | 1.45 | 1.28 | 1.95 | 3.36 |
| Quick ratio | 7.00 | 2.26 | 3.11 | 4.42 | 4.08 |
| Inventory turnover ratio | 7.57 | 5.55 | 4.18 | 4.77 | 5.01 |
Payout ratios | |||||
| Dividend payout ratio (net profit) | 5.37 | 5.15 | 8.21 | 14.67 | 15.22 |
| Dividend payout ratio (cash profit) | 4.94 | 4.79 | 6.99 | 11.59 | 12.29 |
| Earning retention ratio | 91.12 | 94.93 | 92.01 | 85.16 | 84.77 |
| Cash earnings retention ratio | 92.25 | 95.28 | 93.18 | 88.30 | 87.70 |
Coverage ratios | |||||
| Adjusted cash flow time total debt | 7.02 | 1.23 | 5.60 | 8.66 | 5.57 |
| Financial charges coverage ratio | 2.88 | 11.71 | 5.98 | 6.85 | 7.09 |
| Fin. charges cov.ratio (post tax) | 3.50 | 10.59 | 5.02 | 5.86 | 5.69 |
Component ratios | |||||
| Material cost component (% earnings) | 27.84 | 33.87 | 38.22 | 35.45 | 36.64 |
| Selling cost Component | 13.98 | 9.72 | 11.31 | 12.75 | 13.25 |
| Exports as percent of total sales | 25.82 | 49.58 | 39.41 | 26.94 | 26.26 |
| Import comp. in raw mat. consumed | 8.54 | 22.75 | 22.94 | 20.78 | 24.93 |
| Long term assets / total Assets | 0.15 | 0.38 | 0.33 | 0.26 | 0.26 |
| Bonus component in equity capital (%) | 63.21 | 63.67 | 65.95 | 66.69 | 66.75 |